1. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas

   • Ansley Unterberger
   • Thien Nguyen
   • Isaac Yang

   Topic Review 26 February 2021 Pages: 205 - 216

   

2. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma

   • Jacquelyn T. Saunders
   • Brent Holmes
   • Joseph Gera

   Laboratory Investigation 28 January 2021 Pages: 217 - 231

   

3. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR

   • Kedar S. Vaidya
   • Michael J. Mitten
   • Erwin R. Boghaert

   Laboratory Investigation 30 January 2021 Pages: 233 - 243

   

4. Heterogeneity of radiation response in mesenchymal subtype glioblastoma: molecular profiling and reactive oxygen species generation

   • Christopher P. Cifarelli
   • Angelica Jacques
   • Andrey Bobko

   Laboratory Investigation 10 February 2021 Pages: 245 - 255

   

5. Gamma Knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas

   • Lifeng Zhang
   • Wei Chen
   • Jing Chen

   Clinical Study 27 February 2021 Pages: 257 - 264

   

6. Neurotoxicities associated with immune checkpoint inhibitor therapy

   • Sophie L. Duong
   • Frank J. Barbiero
   • Joachim M. Baehring

   Clinical Study 17 January 2021 Pages: 265 - 277

   

7. Evolution of the neurosurgical management of progestin‐associated meningiomas: a 23-year single‐center experience

   • Henri Malaize
   • Thomas Samoyeau
   • Johan Pallud

   Clinical Study 15 January 2021 Pages: 279 - 288

   

8. Between‐hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro Surgery

   • Ivar Kommers
   • Linda Ackermans
   • Philip C. De Witt Hamer

   Clinical Study Open access 28 January 2021 Pages: 289 - 298

   

9. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry

   • Anthony L. Asher
   • Mohammed Ali Alvi
   • Jason Sheehan

   Clinical Study 22 January 2021 Pages: 299 - 311

   

10. How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians

    • Akanksha Sharma
    • Briant Fruth
    • Alyx B. Porter

    Clinical Study 23 January 2021 Pages: 313 - 323

    

11. Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography

    • Sied Kebir
    • Laurèl Rauschenbach
    • Martin Glas

    Clinical Study 27 January 2021 Pages: 325 - 332

    

12. Development of new brain metastases in triple negative breast cancer

    • Ravi Medikonda
    • Siddhartha Srivastava
    • Michael Lim

    Clinical Study 29 January 2021 Pages: 333 - 338

13. Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection

    • Valeri Borger
    • Motaz Hamed
    • Patrick Schuss

    Clinical Study Open access 07 February 2021 Pages: 339 - 346

    

14. Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients

    • Mickael Tordjman
    • Guillaume Madelin
    • Rajan Jain

    Clinical Study 02 February 2021 Pages: 347 - 355

    

15. MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma

    • Matthijs van der Meulen
    • Linda Dirven
    • Jacoline E. C. Bromberg

    Clinical Study Open access 21 February 2021 Pages: 357 - 362

    

16. Intracranial germ cells tumour: a single institution experience in Argentina

    • Lorena V. Baroni
    • Agustina Oller
    • Daniel Alderete

    Clinical Study 03 March 2021 Pages: 363 - 372

    

17. Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study

    • Arbaz A. Momin
    • Jianning Shao
    • Varun R. Kshettry

    Clinical Study 15 February 2021 Pages: 373 - 382

    

18. Poor performance status and brain metastases treatment: who may benefit from the stereotactic radiotherapy?

    • Katarzyna Holub
    • Guillaume Louvel

    Clinical Study 15 February 2021 Pages: 383 - 393

    

19. Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology

    • Johannes Kraft
    • Michael Mayinger
    • Nicolaus Andratschke

    Clinical Study Open access 23 February 2021 Pages: 395 - 404

    

20. Precise detection of the germinomatous component of intracranial germ cell tumors of the basal ganglia and thalamus using placental alkaline phosphatase in cerebrospinal fluid

    • Kentaro Chiba
    • Yasuo Aihara
    • Takakazu Kawamata

    Clinical Study 25 February 2021 Pages: 405 - 413

    

21. Correction to: Clinical outcomes following proton therapy for adult craniopharyngioma: a single‑institution cohort study

    • Michael S. Rutenberg
    • Ronny L. Rotondo
    • William M. Mendenhall

    Correction 22 March 2021 Pages: 415 - 415

22. Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma

    • Rama Rao Malla
    • Sreelatha Gopinath
    • Jasti S. Rao

    Retraction Note 12 March 2021 Pages: 417 - 417